Paradigm Biocapital Advisors LP G1 Therapeutics, Inc. Transaction History
Paradigm Biocapital Advisors LP
- $2.62 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding GTHX
# of Institutions
6Shares Held
3.55MCall Options Held
11.7KPut Options Held
0-
Black Rock Inc. New York, NY3.08MShares$22 Million0.0% of portfolio
-
Tekla Capital Management LLC424KShares$3.03 Million0.04% of portfolio
-
Bdo Wealth Advisors, LLC Jacksonville, FL35.2KShares$251,9230.01% of portfolio
-
Urban Wealth Management, LLC3.66KShares$26,1540.06% of portfolio
-
Trustcore Financial Services, LLC2.05KShares$14,6780.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $306M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...